JP2009530613A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530613A5
JP2009530613A5 JP2009500495A JP2009500495A JP2009530613A5 JP 2009530613 A5 JP2009530613 A5 JP 2009530613A5 JP 2009500495 A JP2009500495 A JP 2009500495A JP 2009500495 A JP2009500495 A JP 2009500495A JP 2009530613 A5 JP2009530613 A5 JP 2009530613A5
Authority
JP
Japan
Prior art keywords
subject
gelsolin
level
composition
multiple sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009500495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530613A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006581 external-priority patent/WO2007106577A2/en
Publication of JP2009530613A publication Critical patent/JP2009530613A/ja
Publication of JP2009530613A5 publication Critical patent/JP2009530613A5/ja
Pending legal-status Critical Current

Links

JP2009500495A 2006-03-15 2007-03-14 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用 Pending JP2009530613A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78250906P 2006-03-15 2006-03-15
PCT/US2007/006581 WO2007106577A2 (en) 2006-03-15 2007-03-14 Gelsolin in the treatment and diagnosis of neurological disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011271607A Division JP6203995B2 (ja) 2006-03-15 2011-12-12 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用

Publications (2)

Publication Number Publication Date
JP2009530613A JP2009530613A (ja) 2009-08-27
JP2009530613A5 true JP2009530613A5 (cg-RX-API-DMAC10.html) 2010-05-06

Family

ID=38510104

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009500495A Pending JP2009530613A (ja) 2006-03-15 2007-03-14 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用
JP2011271607A Active JP6203995B2 (ja) 2006-03-15 2011-12-12 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011271607A Active JP6203995B2 (ja) 2006-03-15 2011-12-12 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用

Country Status (11)

Country Link
US (2) US8440622B2 (cg-RX-API-DMAC10.html)
EP (1) EP2002258B1 (cg-RX-API-DMAC10.html)
JP (2) JP2009530613A (cg-RX-API-DMAC10.html)
CN (1) CN101460843B (cg-RX-API-DMAC10.html)
CA (1) CA2680333C (cg-RX-API-DMAC10.html)
DK (1) DK2002258T3 (cg-RX-API-DMAC10.html)
ES (1) ES2651619T3 (cg-RX-API-DMAC10.html)
HU (1) HUE035980T2 (cg-RX-API-DMAC10.html)
PL (1) PL2002258T3 (cg-RX-API-DMAC10.html)
PT (1) PT2002258T (cg-RX-API-DMAC10.html)
WO (1) WO2007106577A2 (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070238655A1 (en) * 2003-11-12 2007-10-11 The Trustees Of The University Of Pennsylvania Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
US9408891B2 (en) 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
CN1980694B (zh) * 2004-05-12 2012-09-26 布赖汉姆妇女医院有限公司 凝溶胶蛋白治疗感染的用途
JP4348631B2 (ja) * 2005-03-29 2009-10-21 セイコーエプソン株式会社 半導体素子の製造方法
US8198094B2 (en) 2006-03-15 2012-06-12 The Brigham And Women's Hospital, Inc. Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
EP2708603B1 (en) 2008-01-25 2017-04-19 The General Hospital Corporation Diagnostic and therapeutic uses of gelsolin in renal failure
WO2009124226A2 (en) * 2008-04-03 2009-10-08 The Trustees Of The University Of Pennsylvania Gelsolin uses in neurological disorders
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
DE102010026500A1 (de) * 2010-07-07 2012-01-12 Arthrogen Gmbh Verfahren zur Herstellung von autologen Proteinen
WO2012081701A1 (ja) * 2010-12-16 2012-06-21 独立行政法人産業技術総合研究所 髄液型糖タンパク質の富化及び分離方法、並びにその方法を用いた中枢神経系疾患用マーカーの探索方法及び中枢神経系疾患用マーカー
KR101416954B1 (ko) * 2012-09-12 2014-07-16 한양대학교 산학협력단 조혈세포 분화 유도 방법
US10161006B2 (en) 2014-03-11 2018-12-25 Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University) Diagnosis of hematologic diseases
FR3036188B1 (fr) * 2015-05-12 2019-06-07 Biomerieux Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee
JP6947449B2 (ja) * 2016-06-29 2021-10-13 学校法人自治医科大学 バイオマーカー、診断用組成物、及び診断用キット
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
AU2017319728B2 (en) 2016-08-31 2024-09-05 Mapi Pharma Ltd Depot systems comprising glatiramer acetate
IL316573A (en) 2017-03-26 2024-12-01 Mapi Pharma Ltd Storage systems containing glatiramer acetate for the treatment of multiple sclerosis
TWI697499B (zh) * 2018-03-05 2020-07-01 中央研究院 用以診斷周邊神經病變的方法及套組
WO2020263484A1 (en) * 2019-06-28 2020-12-30 Mayo Foundation For Medical Education And Research Methods and materials for treating neuromyelitis optica spectrum diseases
CN116615216A (zh) * 2020-09-23 2023-08-18 生物保护医疗公司 用于鉴定和治疗微粒相关疾病和病症的组合物和方法
CA3196026A1 (en) * 2020-09-23 2022-03-31 Bioaegis Therapeutics Inc. Compositions and methods for identifying and treating microparticle-associated diseases and conditions

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US627353A (en) * 1899-06-20 Cis robinson
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
CA2016227A1 (en) * 1989-05-18 1990-11-18 Xandra O. Breakefield Genetic diagnosis of torsion dystonia
ES2124702T3 (es) 1990-04-11 1999-02-16 Brigham & Womens Hospital Usos terapeuticos de compuestos que se unen a actina.
US5464817A (en) 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
CA2063593A1 (en) 1990-05-04 1991-11-05 Biogen, Inc. Multimeric gelsolin fusion constructs
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5360350A (en) * 1991-08-23 1994-11-01 The Whitaker Corporation Sealant compositions and sealed electrical connectors
US5691160A (en) 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
US5593964A (en) 1993-10-07 1997-01-14 The George Washington University Medical Center Method of treating septic shock by preventing actin polymerization
JP3914272B2 (ja) 1993-12-28 2007-05-16 中外製薬株式会社 アドゼベリンをコードする遺伝子
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5846743A (en) * 1995-02-22 1998-12-08 Brigham And Women's Hospital, Inc. Polyphoshoinositide binding peptides for intracellular drug delivery
US5804427A (en) * 1995-05-19 1998-09-08 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5925529A (en) * 1995-06-07 1999-07-20 The Regents Of The University Of California Method for discovery of peptide agonists
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
DK0941108T3 (da) * 1996-12-04 2002-11-18 Renovo Ltd Sårheling og behandling af fibrose
WO1998043630A1 (en) * 1997-04-02 1998-10-08 Brigham And Women's Hospital, Inc. Means of ascertaining an individual's risk profile for atherosclerotic disease
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US6409599B1 (en) 1999-07-19 2002-06-25 Ham On Rye Technologies, Inc. Interactive virtual reality performance theater entertainment system
WO2002059604A2 (en) 2001-01-26 2002-08-01 Oxford Glycosciences (Uk) Ltd Diagnosis and treatment of multiple sclerosis
EP1249244A1 (en) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
EP2266595A3 (en) 2002-02-06 2011-07-06 Regenerx Biopharmaceuticals, Inc. Treatment of infections and other disorders
WO2003088811A2 (en) 2002-04-16 2003-10-30 The Brigham And Women's Hospital, Inc. Gelsolin as a prognostic marker of artherosclerotic diseases
WO2004001421A2 (en) * 2002-06-21 2003-12-31 Innogenetics N.V. Method for the diagnosis and differential diagnosis of neurological diseases
WO2004023973A2 (en) 2002-09-12 2004-03-25 Incyte Corporation Molecules for diagnostics and therapeutics
US20050048574A1 (en) 2003-03-14 2005-03-03 Kantor Aaron B. Biomarkers for diagnosing rheumatoid arthritis
US20070238655A1 (en) * 2003-11-12 2007-10-11 The Trustees Of The University Of Pennsylvania Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
CN1980694B (zh) * 2004-05-12 2012-09-26 布赖汉姆妇女医院有限公司 凝溶胶蛋白治疗感染的用途
SG183012A1 (en) * 2004-06-04 2012-08-30 Genentech Inc Method for treating multiple sclerosis
DK1929297T3 (da) * 2005-09-29 2013-03-04 Caprion Proteomics Usa Llc Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf
US8198094B2 (en) * 2006-03-15 2012-06-12 The Brigham And Women's Hospital, Inc. Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
EP2708603B1 (en) * 2008-01-25 2017-04-19 The General Hospital Corporation Diagnostic and therapeutic uses of gelsolin in renal failure

Similar Documents

Publication Publication Date Title
JP2009530612A5 (cg-RX-API-DMAC10.html)
BOREL et al. Obesity hypoventilation syndrome: from sleep‐disordered breathing to systemic comorbidities and the need to offer combined treatment strategies
Ryan et al. Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure
Durham CGRP-receptor antagonists-a fresh approach to migraine therapy?
Kircik et al. Anti-TNF agents for the treatment of psoriasis
Ying et al. Water treadmill training attenuates blood-spinal cord barrier disruption in rats by promoting angiogenesis and inhibiting matrix metalloproteinase-2/9 expression following spinal cord injury
MA30287B1 (fr) Procedes de traitement de maladies inflammatoires et auto-immunes avec du natalizumab
Liu et al. Mandibular advancement devices prevent the adverse cardiac effects of obstructive sleep apnea-hypopnea syndrome (OSAHS)
Berger et al. Neurosurgical ablative procedures for intractable cancer pain
Nakamura et al. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
Delakas et al. Extracorporeal shockwave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease
Dudzik et al. The impact of sauna on health
Semple et al. Early gelatinase activity is not a determinant of long-term recovery after traumatic brain injury in the immature mouse
Chi et al. Chronic influences of obstructive sleep apnea on cerebral venous flow
JP2014500327A5 (cg-RX-API-DMAC10.html)
BR0012408A (pt) Métodos para induzir ou aumentar a migração celular, para reduzir ou inibir a migração celular, para induzir ou aumentar a cura de ferimento em um paciente, e para regular a expressão de pelo menos um gene de uma célula, e, uso de um agonista de fator de tecido
Arnaoutakis et al. Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest
WO2005030265A3 (en) Optical imaging of endometriosis
JP2008508253A5 (cg-RX-API-DMAC10.html)
Mahdavi et al. Modeling studies for designing transcranial direct current stimulation protocol in Alzheimer's disease
MX2020011341A (es) Una composicion para el tratamiento de una o mas enfermedades relacionadas con los estrogenos.
Goldstein et al. 106 Use of Zolpidem, a Non-Benzodiazepine Indirect GABA A Receptor Agonist, for Treatment of Persistent Genital Arousal Disorder (PGAD): Mechanism of Action and Preliminary Clinical Experience
Li et al. Effect of combination of parenteral edaravone and nimodipine on ischemic cerebral injury following cerebral hemorrhage
Mukkannavar Effect of combination therapy [TENS and ultrasound] and ischemic compression in the treatment of active myofascial trigger points
Manole et al. Preclinical neurorehabilitation with environmental enrichment confers cognitive and histological benefits in a model of pediatric asphyxial cardiac arrest